In Vitro & In Vivo Preclinical Studies of a Modifier Gene Therapy Candidate for Treating Dry AMD

Time: 11:00 am
day: Day Two


  • Dry-AMD disease pathophysiology and risk factors
  • Modifier gene therapy, an innovative therapeutic approach for treatment of complex multifactorial diseases
  • In vitro and In vivo preclinical studies demonstrating potential of OCU410 gene therapy for dry-AMD